FOXK2 acts as a suppressor in breast cancer, renal clear cell carcinoma, non-small cell lung cancer, and glioma [20–23] but has oncogenic roles in colon cancer, colorectal cancer, and hepatocellular carcinoma [24–26]. Here, FOXK2 is linked to breast carcinoma.